Protagonist Therapeutics, Inc. (PTGX) quarterly cash flow statement — complete operating, investing & financing history
Protagonist Therapeutics, Inc. (PTGX) cash flow statement — 12-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -23.22M | 219.05M | -48.94M | -36.98M | -1.94M | -28.78M | 125.36M | -29.18M | -27.86M | 268.62M | -27.43M | 16.96M | -26.61M | -26.24M | -34.35M | -31.64M | -25.2M | -13.63M | -37.67M | -26.94M |
| Operating CF Margin % | -8.46% | 102.61% | -86.83% | -497.18% | -41.11% | -518.93% | 442.65% | -17.1% | -596% | 6446.41% | -10.76% | 28.27% | - | - | - | - | - | -1587.31% | -146.44% | -312.63% |
| Operating CF Growth % | -1098.81% | 861.13% | -139.04% | -26.72% | 93.05% | -110.71% | 557.05% | -272.04% | -4.7% | 1123.79% | 20.14% | 153.61% | -5.59% | -92.43% | 8.81% | -17.43% | 11.48% | 42.47% | -30.98% | -42.78% |
| Net Income | 220.01M | 162.85M | 3.78M | 85.77M | -39.34M | -34.77M | -11.65M | 131.67M | -33.21M | -30.62M | 207.34M | 27.34M | -34.1M | -38.46M | -33.73M | -34.19M | -31.23M | -41.04M | -20.93M | -36.91M |
| Depreciation & Amortization | 409K | 397K | 407K | 376K | 361K | 304K | 239K | 536K | 647K | 1.48M | 236K | 832K | 827K | 821K | 832K | 840K | 853K | 843K | 833K | 819K |
| Stock-Based Compensation | 14.36M | 14.04M | 14.52M | 10.7M | 10.56M | 10.91M | 13.8M | 9.09M | 10.16M | 8.94M | 9.35M | 6.6M | 6.76M | 8.34M | 7.58M | 5.51M | 5.95M | 6.8M | 5.93M | 5.02M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -282.7M | -604K | -588K | -131.15M | -1.58M | -1.35M | -1.72M | -2.76M | -2.84M | -2.25M | -1.03M | -1.35M | -1.01M | -960K | -1.06M | -914K | -89K | 96K | 358K | 509K |
| Working Capital Changes | 24.69M | 42.37M | -67.06M | -2.67M | 28.06M | -3.88M | 124.69M | -167.72M | -2.63M | 291.06M | -243.33M | -16.46M | 908K | 4.02M | -7.98M | -2.88M | -683K | 19.66M | -23.86M | 3.62M |
| Change in Receivables | 13.29M | 40.25M | -53.54M | 462K | -583K | 538K | 165M | -165M | 43K | 300M | -290.04M | -10M | 39K | 12K | -41K | 82K | 2.64M | 25.11M | -23.58M | 151K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12K | 41K | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 2.46M | -4.9M | 3M | -307K | 2.42M | 375K | 1.24M | -1.43M | -355K | -201K | 2.83M | -597K | -3.2M | 552K | 381K | -1.08M | 3.26M | -6.04M | 5.56M | 895K |
| Cash from Investing | 93.43M | -2.43M | 90.89M | 48.81M | -58.55M | 54.81M | -94.4M | -8.72M | -208.71M | -88.12M | 6.07M | -61.29M | -13.56M | 25.76M | 9.83M | 3.94M | 57.27M | 34.73M | -4.48M | 27.87M |
| Capital Expenditures | -237K | -168K | -215K | 1.45M | -88K | -813K | -545K | -310K | -775K | -28K | -242K | -19K | -404K | -176K | -10K | -70K | -162K | -290K | -273K | -196K |
| CapEx % of Revenue | 0.09% | 0.08% | 0.38% | 19.44% | 1.87% | 14.66% | 1.92% | 0.18% | 16.58% | 0.67% | 0.09% | 0.03% | - | - | - | - | - | 33.76% | 1.06% | 2.27% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25.94M | -9.84M | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -49.32M | 0 | -5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.94M | 9.84M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 8.01M | 9.74M | 23.37M | 2.84M | 5.66M | 2.92M | 11.44M | 4.03M | 12.05M | 2.57M | 7.2M | 527K | 35.31M | 108.17M | 26.46M | 553K | 680K | 680K | 16.93M | 2.17M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 9.74M | 23.37M | 2.84M | 5.66M | 2.92M | 11.92M | 4.03M | 12.05M | 2.57M | 7.8M | 8K | -78K | 107.87M | 24.3M | 0 | 682K | 680K | 14.55M | -166K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -5.79M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 8.01M | 0 | 0 | 0 | 0 | 0 | -479K | 0 | 0 | 0 | -600K | 519K | 35.39M | 304K | 2.16M | 553K | -2K | 0 | 2.37M | 2.34M |
| Net Change in Cash | 78.22M | 226.37M | 65.32M | 14.68M | -54.83M | 28.95M | 42.4M | -33.87M | -224.52M | 183.07M | -14.16M | -43.8M | -4.86M | 107.7M | 1.94M | -27.07M | 32.58M | 21.76M | -25.19M | 3.12M |
| Free Cash Flow | -23.46M | 218.88M | -49.16M | -35.53M | -2.02M | -29.59M | 124.82M | -29.49M | -28.64M | 268.59M | -27.67M | 16.94M | -27.02M | -26.41M | -34.36M | -31.7M | -25.36M | -13.93M | -37.94M | -27.14M |
| FCF Margin % | -8.55% | 102.53% | -87.21% | -477.73% | -42.98% | -533.59% | 440.73% | -17.28% | -612.58% | 6445.74% | -10.85% | 28.23% | - | - | - | - | - | -1621.07% | -147.5% | -314.9% |
| FCF Growth % | -1058.42% | 839.65% | -139.38% | -20.49% | 92.93% | -111.02% | 551.08% | -274.06% | -6.01% | 1116.86% | 19.46% | 153.43% | -6.51% | -89.69% | 9.44% | -16.84% | 11.73% | 42.46% | -31.3% | -42.88% |
| FCF per Share | -0.33 | 3.08 | -0.70 | -0.56 | -0.03 | -0.47 | 1.98 | -0.44 | -0.46 | 4.38 | -0.44 | 0.27 | -0.46 | -0.47 | -0.68 | -0.64 | -0.52 | -0.28 | -0.78 | -0.56 |
| FCF Conversion (FCF/Net Income) | -0.11x | 1.35x | -12.94x | 0.83x | 0.05x | 0.83x | -10.76x | -0.22x | 0.84x | -8.77x | -0.13x | 0.62x | 0.78x | 0.68x | 1.02x | 0.93x | 0.81x | 0.33x | 1.80x | 0.73x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |